Evidence map›Paper›PMID 36758612›Full record

ArticleThrombosis and haemostasis2023

Contemporary Management and Clinical Course of Acute Pulmonary Embolism: The COPE Study.

Cecilia Becattini, Giancarlo Agnelli, Aldo P Maggioni, Francesco Dentali, Andrea Fabbri, Iolanda Enea, Fulvio Pomero, Maria Pia Ruggieri, Andrea di Lenarda, Ludovica Anna Cimini and 5 more

Registry-linked trialOpen access · hybridAbstract readMulticenter Study
In one paragraph

Article in Thrombosis and haemostasis, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03631810 (Contemporary Clinical Management Of Acute Pulmonary Embolism. The COPE Study), which is not on this map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
8.3field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03631810 completednot on this map

Contemporary Clinical Management Of Acute Pulmonary Embolism. The COPE Study

Typeobservational_patient_registrySponsorHeart Care FoundationRan2018 to 2021Enrolled5,213ConditionsAcute Pulmonary Embolism
3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 30 citations in OpenAlex.

  1. Trial
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Use of the PaOJournal of thoracic disease · 2025
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Prevention of thromboembolism after a fracture: is aspirin enough?European heart journal supplements : journal of the European Society of Cardiology · 2024
    Article
  14. Addressing the rising trend of high-risk pulmonary embolism mortality: Clinical and research priorities.Academic emergency medicine : official journal of the Society for Academic Emergency Medicine · 2024
    Article
  15. Provoked vs minimally provoked vs unprovoked VTE: does it matter?Hematology. American Society of Hematology. Education Program · 2023
    Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 10 institutions in 1 country.

Cecilia BecattiniInternal, Vascular and Emergency Medicine-Stroke Unit, University of Perugia, Perugia, Italy.
Giancarlo AgnelliInternal, Vascular and Emergency Medicine-Stroke Unit, University of Perugia, Perugia, Italy.
Aldo P MaggioniANMCO Research Center, Heart Care Foundation, Florence, Italy.
Francesco DentaliDepartment of Clinical and Experimental Medicine, Insubria University, Varese, Italy.ORCID 0000-0003-4195-7725
Andrea FabbriEmergency Department, "Presidio Ospedaliero Morgagni-Pierantoni," Forlì, Italy.
Iolanda EneaU.O.C. Medicina e Chirurgia d'Urgenza, A.O.R.N. "S. Anna e S. Sebastiano," Caserta, Italy.
Fulvio PomeroDivision of Internal Medicine, Michele and Pietro Ferrero Hospital, Verduno, Italy.
Maria Pia RuggieriU.O.C. Medicina d'Urgenza e Pronto Soccorso, AO San Giovanni Addolorata, Roma, Italy.
Andrea di LenardaCardiovascular Center, University Hospital and Health Services of Trieste, Italy.
Ludovica Anna CiminiInternal, Vascular and Emergency Medicine-Stroke Unit, University of Perugia, Perugia, Italy.
Giuseppe PepePS e Medicina d'Urgenza, Nuovo Ospedale Versilia, Lido di Camaiore, Italy.
Susanna CozzioMedicina Interna, Ospedale S. Maria del Carmine, Rovereto, Italy.
Donata LucciANMCO Research Center, Heart Care Foundation, Florence, Italy.
Michele M GuliziaANMCO Research Center, Heart Care Foundation, Florence, Italy.
COPE Investigators
Associazione Nazionale Medici Cardiologi Ospedalieri · ITUniversity of Perugia · ITAzienda Ospedaliera San Giovanni Addolorata · ITI.R.C.C.S. Oasi Maria SS · ITOspedale San Pietro Fatebenefratelli · ITOspedale Santa Maria · ITOspedale Versilia · ITPresidio Ospedaliero · ITUniversity of Insubria · ITUniversity of Trieste · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundNew diagnosis, risk stratification, and treatment strategies became recently available for patients with acute pulmonary embolism (PE) leading to changes in clinical practice and potentially influencing short-term patients' outcomes. RESEARCH QUESTION: The COntemporary management of PE (COPE) study is aimed at assessing the contemporary clinical management and outcomes in patients with acute symptomatic PE. STUDY DESIGN AND

methodsProspective, noninterventional, multicenter study. The co-primary study outcomes, in-hospital and 30-day death, were reported overall and by risk categories according to the European Society of Cardiology (ESC) and American Heart Association guidelines.

resultsAmong 5,213 study patients, PE was confirmed by computed tomography in 96.3%. In-hospital, 289 patients underwent reperfusion (5.5%), 92.1% received parenteral anticoagulants; at discharge, 75.6% received direct oral anticoagulants and 6.7% vitamin K antagonists. In-hospital and 30-day mortalities were 3.4 and 4.8%, respectively. In-hospital death occurred in 20.3% high-risk patients (

conclusionFor the majority of patients with PE, contemporary initial management includes risk stratification and treatment with direct oral anticoagulants. In-hospital mortality remains high in intermediate and high-risk patients calling for and informing research focused on its reduction. TRIAL REGISTRATION NUMBER: NCT03631810.

Indexed as

Pulmonary EmbolismAcute DiseaseAnticoagulantsDisease ProgressionHospital MortalityHumansPrognosisProspective StudiesRisk AssessmentAnticoagulants

Identifiers

PMID36758612
PMCPMC10205399
OpenAlexW4319660345

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.